{"nct_id":"NCT02393378","title":"Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate","status":"TERMINATED","status_verified_date":"2018-08","start_date":"2015-04-08","start_date_type":"ACTUAL","primary_completion_date":"2016-06-27","primary_completion_date_type":"ACTUAL","completion_date":"2016-11-16","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}